First of all, I will acknowledge that there is significant strength in eastern Canada as well, and specifically Dalhousie. Our researchers right now are working with teams there collaboratively. I don't want there to be a message left today that there is not existing collaboration in our country.
With respect to barriers, one approach that's used at Sunnybrook, which we believe is a model that others should emulate, is treating those with disorders of the brain and mind together. Helping to destigmatize mental illness is a major undertaking right now in our country. By having individuals who have depression in the same clinic area as those who may have dementia, or stroke, or other diseases of the brain, is a major step forward. We believe that cooperative model within organizations is important.
I have already mentioned the importance of networking to make sure we have collaborative research taking place not only across the country but across the world.
With respect to commercialization initiatives, we're starting to make progress in certain clusters across the country. We very much favour the cluster environment, where we can bring together those with public and private sector expertise and interest. We believe that by having a strategy around disorders of the brain and mind, we'll be better positioned to capitalize on commercialization opportunities, as I mentioned, growing jobs and companies.